- Investing Ideas
- Hong Kong Healthcare Undervalued based on future growth
Hong Kong Healthcare Undervalued based on future growth
Results
7
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
7 companies
Sinopharm Group
Market Cap: HK$52.7b
Engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People’s Republic of China.
1099
HK$17.08
7D
0.2%
1Y
-10.7%
Beijing Chunlizhengda Medical Instruments
Market Cap: HK$5.9b
Beijing Chunlizhengda Medical Instruments Co., Ltd.
1858
HK$9.26
7D
-3.4%
1Y
-17.3%
Hygeia Healthcare Holdings
Market Cap: HK$5.5b
Offers oncology healthcare services in the People's Republic of China.
6078
HK$8.93
7D
-8.9%
1Y
-45.5%
LEPU ScienTech Medical Technology (Shanghai)
Market Cap: HK$3.2b
An investment holding company, engages in the manufacture and sale of interventional treatment series occluders and heart valve medical devices.
2291
HK$9.31
7D
-4.0%
1Y
-58.8%
Chaoju Eye Care Holdings
Market Cap: HK$1.8b
Owns and operates a network of ophthalmic hospitals and centers in the People’s Republic of China.
2219
HK$2.54
7D
-0.8%
1Y
-9.9%
Sisram Medical
Market Cap: HK$1.2b
Engages in the research, design, development, manufacture, sale, and marketing of medical aesthetics and dental equipment, home-use devices, injectables, and cosmeceutical products in the Asia Pacific, North America, Europe, the Middle East, Africa, and Latin America.
1696
HK$2.50
7D
-6.7%
1Y
-49.2%
Yonghe Medical Group
Market Cap: HK$1.1b
Provides hair-related healthcare services in China.
2279
HK$2.08
7D
1.5%
1Y
62.5%